Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report

Clinical use of HD-MTX monotherapy in a rare case of refractory primary bone diffuse large B-cell lymphoma with long-term survival after local radiotherapy: A case report

Primary bone diffuse large B-cell lymphoma (PB-DLBCL) has been rarely reported because of its low incidence. The optimal treatment plan for patients with relapsed/refractory PB-DLBCL remains controversial. In this study, we present a case of a 57-year-old patient with refractory PB-DLBCL to better u...

Full description

Bibliographic Details
Main Authors: Zhiya Wu, Yue Teng, Jianqiu Wu, Honglu Zhang, Weiwei Peng, Cheng Meng, Weiyan Tang, Jifeng Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Medicine
Subjects:
methotrexate
primary bone lymphoma
primary bone diffuse large B-cell lymphoma
refractory
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.989590/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.989590/full

Similar Items